HTA18 First to launch, first to falter?:an investigation into the clinical benefits and HTA outcomes for first-in-class drugs

Civitelli, D.

; Politopoulou, K.; Mills, Mackenzie; and Kanavos, P.

(2024) HTA18 First to launch, first to falter?:an investigation into the clinical benefits and HTA outcomes for first-in-class drugs. Value in Health, 27 (12, Supplement). S356 - S356. ISSN 1098-3015

Copy

Item Type	Article
Keywords	AAM not requested
Departments	LSE Health Health Policy ?? MTRG ??
DOI	10.1016/j.jval.2024.10.1843
Date Deposited	20 Mar 2025 15:18
URI	https://researchonline.lse.ac.uk/id/eprint/127609

Explore Further

Civitelli, D.
Politopoulou, K.
Mills, Mackenzie
Kanavos, P.

R Medicine (General)
RM Therapeutics. Pharmacology

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=lse-pure-import-candidates&SrcAuth=WosAPI&KeyUT=WOS:001426382000186&DestLinkType=FullRecord&DestApp=WOS_CPL
10.1016/j.jval.2024.10.1843 (DOI)

Full text not available from this repository.

Atom

BibTeX

OpenURL ContextObject in Span

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

Data Cite XML

EndNote

HTML Citation

METS

MODS

RIOXX2 XML

Reference Manager

Refer

ASCII Citation

Export

Downloads